Posted on 18 September 2012 by Administrator
Qsymia (pronounced kyoo-SIM-ee-uh), the new diet pill which was finally approved by the U.S. Food and Drug Administration this July is now available for prescription to obese or at-risk overweight patients. The oral medication can only be obtained by patients with their doctor’s prescription and comes with a number of special conditions.
Doctors are allowed to prescribe the phentermine based drug to any patients but there are a number of serious issues including the possibility that physicians will open “diet pill mills” and prescribe it to mildly overweight patients who simply want a quick way to lose a few pounds.
Qsymia has been approved by the FDA and is designed to be used as an adjunct to a lowered calorie diet plan and increased excercise for chronic weight management in obese adult patients. As the first new medication available in 13 years for the treatment of obesity, Qsymia is set to be a popular weight loss drug for manufacturer Vivus.
VIVUS has introduced the Qsymia Risk Evaluation and Mitigation Strategy (REMS) program as a way to help educated healthcare providers as well as patients to the side effects and proper usage of this powerful weight loss drug.
If you are suffering from a serious weight problem and need help with weight loss you should contact your doctor to determine if Qsymia is the right course of action for you.Tags: phentermine, qsymia, Vivus, weight loss